Show simple item record

dc.contributor.authorNorman, Richard
dc.contributor.authorWatts, G.
dc.contributor.authorWeintraub, W.
dc.contributor.authorGidding, S.
dc.date.accessioned2017-03-15T22:24:02Z
dc.date.available2017-03-15T22:24:02Z
dc.date.created2017-03-08T06:39:32Z
dc.date.issued2016
dc.identifier.citationNorman, R. and Watts, G. and Weintraub, W. and Gidding, S. 2016. Challenges in the health economics of familial hypercholesterolemia. Current Opinion in Lipidology. 27 (6): pp. 563-569.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/50406
dc.identifier.doi10.1097/MOL.0000000000000365
dc.description.abstract

Purpose of review: Implementation of effective interventions often requires evidence regarding value, that is, whether they are worth what we pay for them. This review explores recent evidence concerning cost-effectiveness in familial hypercholesterolemia, and discusses the cause of, and likelihood of solutions to, the paucity of such evidence. Recent findings: Cost-effectiveness analysis in familial hypercholesterolemia has been limited almost exclusively to adult populations. However, there is growing evidence that childhood intervention offers substantial benefit in terms of downstream health gains. Statin therapy in adults has been demonstrated to be cost-effective, but the range of novel agents that might be used will require de novo economic evaluation alongside exploration of their effect and safety profile. Summary: The familial hypercholesterolemia field has limited evidence regarding cost-effectiveness, which limits optimum allocation of resources. Economic evaluations are necessary to appraise new agents and optimal timing of management approaches. Evaluations often have substantial data demands; consequentially, their applicability to medical decision-making or policy will be partly determined by the availability of data, particularly those providing information about the long-term trajectory of health benefit from familial hypercholesterolemia treatment. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

dc.publisherLippincott Williams & Wilkins
dc.titleChallenges in the health economics of familial hypercholesterolemia
dc.typeJournal Article
dcterms.source.volume27
dcterms.source.number6
dcterms.source.startPage563
dcterms.source.endPage569
dcterms.source.issn0957-9672
dcterms.source.titleCurrent Opinion in Lipidology
curtin.departmentDepartment of Health Policy and Management
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record